Either hydroxyurea or busulfan as single agents can provide hematologic control in the majority of patients (> 75%) with chronic phase CML. [32] These hematologic "remissions" are characterized by ...

Thirst is our body's way of letting us know that it needs water. When we do not have enough fluid in the body, our blood volume decreases, which in turn causes a decrease in our blood pressure. The ...

Erratum: Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial ...

Notwithstanding a recent easing of supply constraints for some weight-loss medicines, the country is still mired in a record prescription drug shortage. The American Medical Association (AMA), the ...

Various clinical trials have evaluated the clinical value of an initial dose intensification of imatinib in CML-CP patients (an overview of the most important response rates is given in Table 1 ...

We were the first in Europe to develop chemotherapeutic agents, and we discovered, and with The Royal Marsden NHS Foundation Trust developed, the chemotherapy drugs busulfan, chlorambucil, melphalan ...

Acute lymphocytic leukaemia (ALL) is a cancer of the blood and bone marrow, specifically affecting lymphocytes. The disease progresses rapidly and creates immature blood cells, rather than mature ...

Erratum: Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial The ...